SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Target Corp. engages in the operation and ownership of general merchandise stores. It offers food and general merchandise, clothing and household goods, electronics, and toys. Its brands include A New Day, All in Motion, Art Class, Auden, AVA & VIV, Boots and Barkley, Brightroom, Bullseye's Playground, Casaluna, Cat & Jack, Cloud Island, Colsie, dealworthy, Embark, Everspring, Favorite Day, Figmint, Future Collective, Gigglescape, Good & Gather, Goodfellow & Co, Hearth & Hand with Magnolia, Heyday, Hyde & EEK! Boutique, JoyLab, Kindfull, Kona Sol, Made By Design, Market Pantry, Mondo Llama, More Than Magic, Opalhouse, Open Story, Original Use, Pillowfort, Project 62, Room Essentials, Shade & Shore, Smartly, Smith & Hawken, Sonia Kashuk, Spritz, Sun Squad, Threshold, Universal Thread, up&up, Wild Fable, Wondershop, Xhilaration, California Roots, Casa Cantina, The Collection, Headliner, Jingle & Mingle, Rosé Bae, Photograph, SunPop, and Wine Cube. The company was founded by George Draper Dayton in 1902 and is headquartered in Minneapolis, MN.

Target Corp

Target ($TGT) is trending as investors assess its potential turnaround, focusing on its attractive valuation and upcoming earnings report. Community members are weighing the impact of restructuring and cost-cutting measures, while noting the dividend yield. Bullish sentiment is building, with some anticipating a run toward higher price targets amid broader discussions of retail sector dynamics.

Kazia Therapeutics Ltd. is an oncology-focused biotechnology company, which engages in the business of pharmaceutical drug development. It focuses on its Paxalisib program, which is designed to treat brain cancer. The company was founded by Graham Edmund Kelly in March 1994 and is headquartered in Sydney, Australia.

Kazia Therapeutics Limited - ADR

Kazia Therapeutics

KZIA is trending due to positive initial results from a Phase 1b trial for triple-negative breast cancer, showing a significant reduction in tumor cells. The community is discussing the potential of paxalisib, combined with Keytruda and chemotherapy, to become a game-changer in cancer treatment. Some are closely watching for potential dilution, while others are optimistic about upcoming milestones and strategic partnerships.

Memecoin on Cronos launched by the Cro Crow community

crow with knife

The $CAW community is actively promoting the meme coin, emphasizing its multi-chain presence and organic growth. Recent discussions highlight the coin's unique deflationary mechanism and partnerships within the crypto space. Community members express bullish sentiment, viewing $CAW as a potential disruptor in the market.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Chatham, NJ.

Tonix Pharmaceuticals Holding Corp

TNXP is trending following the announcement of an increase to its share repurchase program, authorizing up to $35 million. The community is actively debating the potential impact of the buyback, especially in light of past dilution and a commercial product launch. Sentiment is mixed, with some bulls optimistic about a turnaround and potential short squeeze, while bears remain skeptical of management.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA's earnings are the main topic, with the community anticipating a significant market reaction regardless of the outcome; many traders are expressing concerns about the sustainability of AI investments. There's also discussion around potential deals with Saudi Arabia and the impact of a possible investment in $DJT.

Lowe's Companies, Inc. engages in the retail sale of home improvement products. The firm offers products for maintenance, repair, remodeling, home decorating, and property maintenance. It also provides home improvement products in the following categories: appliances, seasonal & outdoor living, lumber, lawn & garden, kitchens & bath, hardware, building materials, millwork, paint, rough plumbing, tools, electrical, flooring, and décor. The company was founded in 1946 and is headquartered in Mooresville, NC.

Lowe`s Cos., Inc.

Lowe's Companies, Inc.

Lowe's is trending following the release of its latest earnings report, which beat expectations despite a mixed outlook for the year. Community discussion revolves around the company's performance relative to competitor Home Depot and its ability to navigate a challenging home improvement market. Investors are also weighing the impact of potential interest rate cuts and the company's strategic initiatives, including investments in AI and the Pro segment.

Sigma Lithium Corp. engages in the producing of a lithium property. It focuses its project in Minas Gerais. The firm also plans to build a world-class commercial-scale lithium concentration plant. The company was founded on June 8, 2011 and is headquartered in Sao Paulo, Brazil.

Sigma Lithium Corporation

SGML is trending as lithium stocks gain momentum, fueled by rising lithium prices and production updates. Community discussions revolve around short squeezes and potential upside, while others express concern over potential offerings. The stock's recent overnight gains and unified bullish expectations also contribute to the heightened interest.

Wix.com Ltd. operates a cloud-based website design and development platform. It offers web templates, web editor, web builder, search engine optimization tools, logo maker, web hosting, and electronic mail marketing services. The company was founded by Avishai Abrahami, Nadav Abrahami, and Giora Kaplan on October 5, 2006, and is headquartered in Tel Aviv, Israel.

Wix.com Ltd

Wix is trending amid analyst upgrades and increased price targets, with the community actively discussing the company's growth potential in the AI-driven web development space. A recent strategic partnership with PayPal to enhance AI-powered product discovery is adding to the bullish sentiment. Despite some mixed analyst sentiments and a history of inconsistent profitability, Wix's innovative product offerings are a key focus for investors.

Blue Gold Ltd. engages in the sole purpose of effecting the transactions contemplated by the business combination agreement. The company is headquartered in George Town, Cayman Islands.

Blue Gold Ltd. - Ordinary Shares - Class A

Blue Gold Limited Class A Ordinary Shares

Blue Gold Limited is trending amidst developments at the Bogoso Prestea mine, where illegal mining activity resulted in fatalities, sparking community concerns and scrutiny of Heath Goldfields' management. The community is closely watching for official statements and the outcome of investigations, with discussions focusing on the potential lease disputes and the future of the mine. News of Blue Gold's digital gold initiatives and strategic partnerships are also contributing to the ongoing conversation.

What is the project about?   Horizen is a modular privacy-first platform designed to make privacy technology, such as zero-knowledge proofs and TEEs accessible and usable across the web. Originally launched in 2017 as a fair launch, non-ICO project, Horizen is now undergoing a major evolution with the launch of Horizen 2.0, a next-generation Layer 3 (L3) appchain deployed on Base, the Ethereum Layer 2 developed by Coinbase.  Horizen 2.0 is built as an Ethereum-aligned Layer 3 appchain on Base, inheriting Ethereum's security while implementing its own application-level integrity guarantees.    Key components of Horizen’s security model include:  Ethereum-Aligned Security: As an appchain deployed on Base, Horizen 2.0 benefits from Base’s rollup security and settlement on Ethereum, ensuring robust finality and composability with other L2 and L3 applications.  Simplified and Secure Architecture: Unlike Horizen’s previous iterations (which used a hybrid PoW/PoS model), Horizen 2.0 focuses on application-level security, decentralization of its privacy layers, and composability with existing infrastructure — reducing complexity and increasing user safety.  Decentralized Privacy Stack: Horizen’s focus on decentralizing privacy infrastructure (e.g., decentralized proof generation) allows for modular, secure applications that uphold data confidentiality without compromising performance.    What makes your project unique?  Privacy-first Approach: Horizen integrates a diverse stack of privacy-enhancing technologies (PETs) — including zero-knowledge proofs (ZKPs), trusted execution environments (TEEs), attribute-based encryption (ABE), multi-party computation (MPC), and fully homomorphic encryption (FHE) — to deliver scalable, flexible, and future-ready privacy solutions across its platform.  First Privacy Appchain on Base: As an L3 on Base, Horizen benefits from Ethereum’s security and Base’s scalability, while enabling a privacy layer for any app on the network. This unlocks new possibilities for private identity, DeFi, onchain gaming, and compliant confidential transactions.  Zero-Knowledge, Without the Trade-Offs: Horizen 2.0 scales ZK privacy and verification by integrating with leading zk infrastructure providers such as Fermah, zkVerify, and Singularity, optimizing proof generation for performance, cost-efficiency, and developer usability.  Token Utility Expansion: ZEN’s updated tokenomics allocates 5 million unminted tokens toward strategic ecosystem growth. ZEN powers DAO governance, serves as a payment token in privacy apps, and supports a sustainability fund to accelerate privacy innovation.  Developer-Centric Design: With EVM compatibility, privacy-friendly tooling, and the ability to embed privacy directly into smart contracts, Horizen allows developers to build privacy-first apps without requiring deep cryptographic expertise.  DAO-Led Governance: Governed by the Horizen DAO and shaped through community proposals (ZENIPs), Horizen is evolving as a fully decentralized protocol with transparent development and decision-making.    What can your coin/token be used for?  Horizen 2.0 delivers performance, privacy, and scalability for developers building privacy-enabled and compliance-friendly applications, with significantly reduced cost and latency.  At the core of the ecosystem is ZEN, the native utility token used for governance, accessing privacy services, and fueling zkApp interactions. With its migration to Base, ZEN becomes an ERC-20 token, improving liquidity, interoperability, and composability across the broader Ethereum ecosystem.

ZenCash

ZEN Crypto is trending as traders discuss its potential following recent movements in sister cryptocurrencies, along with speculation around new platform listings and regulatory compliance for this privacy coin. Community members highlight ZEN's limited supply and potential for significant price appreciation. Discussions also include technical analysis, potential breakouts, and comparisons to similar tokens.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Campbell & CO Investment Adviser LLC Buys Shares of 83,245 Zevra Therapeutics, Inc. $ZVRA

Campbell & CO Investment Adviser LLC purchased a new position in Zevra Therapeutics, Inc. (NASDAQ:ZVRA - Free Report) in the second quarter, according to its most recent Form 13F filing with the...

Los Angeles Capital Management LLC Buys Shares of 121,225 Zevra Therapeutics, Inc. $ZVRA

Los Angeles Capital Management LLC purchased a new stake in shares of Zevra Therapeutics, Inc. (NASDAQ:ZVRA - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F...

Research Analysts Set Expectations for ZVRA FY2025 Earnings

Zevra Therapeutics, Inc. (NASDAQ:ZVRA - Free Report) - Investment analysts at William Blair lifted their FY2025 earnings estimates for Zevra Therapeutics in a research report issued to clients and...

FY2025 EPS Estimate for Zevra Therapeutics Raised by Analyst

Zevra Therapeutics, Inc. (NASDAQ:ZVRA - Free Report) - Equities researchers at HC Wainwright raised their FY2025 earnings per share (EPS) estimates for Zevra Therapeutics in a note issued to...

William Blair Analysts Boost Earnings Estimates for ZVRA

Zevra Therapeutics, Inc. (NASDAQ:ZVRA - Free Report) - William Blair lifted their Q3 2026 earnings per share (EPS) estimates for shares of Zevra Therapeutics in a report issued on Wednesday, November...

FY2026 EPS Estimates for ZVRA Decreased by Cantor Fitzgerald

Zevra Therapeutics, Inc. (NASDAQ:ZVRA - Free Report) - Equities research analysts at Cantor Fitzgerald cut their FY2026 EPS estimates for shares of Zevra Therapeutics in a note issued to investors on...

Zevra Therapeutics (NASDAQ:ZVRA) Upgraded to "Buy" at Wall Street Zen

Wall Street Zen upgraded Zevra Therapeutics from a "hold" rating to a "buy" rating in a research report on Saturday...

Zevra Therapeutics (NASDAQ:ZVRA) Given New $24.00 Price Target at Cantor Fitzgerald

Cantor Fitzgerald decreased their price target on shares of Zevra Therapeutics from $29.00 to $24.00 and set an "overweight" rating for the company in a research note on Thursday...

Zevra Therapeutics (NASDAQ:ZVRA) Announces Quarterly Earnings Results, Beats Expectations By $0.03 EPS

Zevra Therapeutics (NASDAQ:ZVRA - Get Free Report) released its quarterly earnings data on Wednesday. The company reported ($0.01) earnings per share for the quarter, beating the consensus estimate...

Zevra Therapeutics (ZVRA) Reports Q3 Loss, Lags Revenue Estimates

Zevra Therapeutics (ZVRA) delivered earnings and revenue surprises of +75.00% and -1.77%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

ZVRA
Zevra Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest ZVRA News

ZVRAZevra Therapeutics Inc